60 related articles for article (PubMed ID: 330780)
1. Neonatal meningitis due of Escherichia coli K1.
Glode MP; Sutton A; Robbins JB; McCracken GH; Gotschlich EC; Kaijser B; Hanson LA
J Infect Dis; 1977 Aug; 136 Suppl():S93-7. PubMed ID: 330780
[TBL] [Abstract][Full Text] [Related]
2. A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections.
Sereme Y; Schrimp C; Faury H; Agapoff M; Lefebvre-Wloszczowski E; Chang Marchand Y; Ageron-Ardila E; Panafieu E; Blec F; Coureuil M; Frapy E; Tsatsaris V; Bonacorsi S; Skurnik D
Nat Commun; 2024 Apr; 15(1):3021. PubMed ID: 38589401
[TBL] [Abstract][Full Text] [Related]
3. The molecular characterisation of Escherichia coli K1 isolated from neonatal nasogastric feeding tubes.
Alkeskas A; Ogrodzki P; Saad M; Masood N; Rhoma NR; Moore K; Farbos A; Paszkiewicz K; Forsythe S
BMC Infect Dis; 2015 Oct; 15():449. PubMed ID: 26497222
[TBL] [Abstract][Full Text] [Related]
4. Bioluminescent imaging reveals novel patterns of colonization and invasion in systemic Escherichia coli K1 experimental infection in the neonatal rat.
Witcomb LA; Collins JW; McCarthy AJ; Frankel G; Taylor PW
Infect Immun; 2015 Dec; 83(12):4528-40. PubMed ID: 26351276
[TBL] [Abstract][Full Text] [Related]
5. Letter: Susceptibility to group B meningococcal vs. Escherichia coli K1 disease.
Ericsson CD
N Engl J Med; 1975 Apr; 292(14):755. PubMed ID: 803639
[No Abstract] [Full Text] [Related]
6. Escherichia coli K1 induces pterin production for enhanced expression of Fcγ receptor I to invade RAW 264.7 macrophages.
Shanmuganathan MV; Krishnan S; Fu X; Prasadarao NV
Microbes Infect; 2014 Feb; 16(2):134-41. PubMed ID: 24161960
[TBL] [Abstract][Full Text] [Related]
7. High-risk
Nhu NTK; Phan MD; Hancock SJ; Peters KM; Alvarez-Fraga L; Forde BM; Andersen SB; Miliya T; Harris PNA; Beatson SA; Schlebusch S; Bergh H; Turner P; Brauner A; Westerlund-Wikström B; Irwin AD; Schembri MA
Elife; 2024 Apr; 12():. PubMed ID: 38622998
[TBL] [Abstract][Full Text] [Related]
8. Comparative label-free proteomics of the neonatal meningitis-causing
Zlatkov N; Gunnari W; Resch U
Microbiol Resour Announc; 2024 Feb; 13(2):e0096023. PubMed ID: 38289054
[TBL] [Abstract][Full Text] [Related]
9. E. coli meningitis: K1 antigen and virulence.
Wilfert CM
Annu Rev Med; 1978; 29():129-36. PubMed ID: 348030
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action, antimicrobial activity, pharmacology, adverse effects, and clinical efficacy of cefotaxime.
LeFrock JL; Prince RA; Leff RD
Pharmacotherapy; 1982; 2(4):174-84. PubMed ID: 6302641
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.
Robbins JB; McCracken GH; Gotschlich EC; Orskov F; Orskov I; Hanson LA
N Engl J Med; 1974 May; 290(22):1216-20. PubMed ID: 4133095
[No Abstract] [Full Text] [Related]
12. Epidemiology of Escherichia coli K1 in healthy and diseased newborns.
Sarff LD; McCracken GH; Schiffer MS; Glode MP; Robbins JB; Orskov I; Orskov F
Lancet; 1975 May; 1(7916):1099-104. PubMed ID: 49468
[TBL] [Abstract][Full Text] [Related]
13. Determination of a gentamicin loading dose in neonates and infants.
Semchuk W; Borgmann J; Bowman L
Ther Drug Monit; 1993 Feb; 15(1):47-51. PubMed ID: 8451781
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of bacterial resistance to antimicrobial agents, with particular reference to cefotaxime and other beta-lactam compounds.
Neu HC
Rev Infect Dis; 1982; 4 Suppl():S288-99. PubMed ID: 6294778
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of cefotaxime: a review.
Lassman HB; Coombes JD
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):3S-12S. PubMed ID: 6086216
[TBL] [Abstract][Full Text] [Related]
17. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary and functional history of the Escherichia coli K1 capsule.
Arredondo-Alonso S; Blundell-Hunter G; Fu Z; Gladstone RA; Fillol-Salom A; Loraine J; Cloutman-Green E; Johnsen PJ; Samuelsen Ø; Pöntinen AK; Cléon F; Chavez-Bueno S; De la Cruz MA; Ares MA; Vongsouvath M; Chmielarczyk A; Horner C; Klein N; McNally A; Reis JN; Penadés JR; Thomson NR; Corander J; Taylor PW; McCarthy AJ
Nat Commun; 2023 Jun; 14(1):3294. PubMed ID: 37322051
[TBL] [Abstract][Full Text] [Related]
19. Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular
Williams J; Kerven J; Chen Y; Sagona AP
ACS Synth Biol; 2023 Jul; 12(7):2094-2106. PubMed ID: 37318278
[TBL] [Abstract][Full Text] [Related]
20. Improved methods to characterize the length and quantity of highly unstable PolySialic acids subject category: (Carbohydrates, chromatographic techniques).
Vaill M; Chen DY; Diaz S; Varki A
Anal Biochem; 2021 Dec; 635():114426. PubMed ID: 34687617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
